Literature DB >> 32660328

RETRACTED ARTICLE: DGUOK-AS1 promotes the proliferation cervical cancer through regulating miR-653-5p/EMSY.

Anqi Yan1, Guanhao Chen1, Jichan Nie1.   

Abstract

Statement of RetractionArticle title: DGUOK-AS1 promotes the proliferation cervical cancer through regulating miR-653-5p/EMSYAuthors: Yan A, Chen G, and Nie, J.Journal: Cancer Biology & TherapyDOI: https://doi.org/10.1080/15384047.2020.1775445In the version of DGUOK-AS1 promotes the proliferation cervical cancer through regulating miR-653-5p/EMSY by Anqi Yan, Guanhao Chen and Jichan Nie published online July 13, 2020, the authors noted inconsistencies within Figures 1F, 2B, 2L, and 4E. Upon investigation, it was determined that the images are unable to support the findings of the manuscript and the article should subsequently be retracted.The Authors apologise for any inconvenience caused.

Entities:  

Year:  2020        PMID: 32660328      PMCID: PMC8726694          DOI: 10.1080/15384047.2020.1775445

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  3 in total

1.  Long non‑coding RNA LINC01006 exhibits oncogenic properties in cervical cancer by functioning as a molecular sponge for microRNA‑28‑5p and increasing PAK2 expression.

Authors:  Libin Tian; Feng Han; Jing Yang; Xiaoqiong Ming; Lili Chen
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

2.  miR-653-5p suppresses the viability and migration of fibroblast-like synoviocytes by targeting FGF2 and inactivation of the Wnt/beta-catenin pathway.

Authors:  Peilong Dong; Xiaobo Tang; Jian Wang; Botao Zhu; Zhiyun Li
Journal:  J Orthop Surg Res       Date:  2022-01-04       Impact factor: 2.359

3.  Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.

Authors:  Qiuyu Lin; Qianle Qi; Sen Hou; Zhen Chen; Nan Jiang; Laney Zhang; Chenghe Lin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.